Dabur, Maruti, Apollo Hospitals, Bajaj Finance stocks in focus with Union Budget initiating consumption-led economic recovery ...

Apollo Tyres Ltd is quoting at Rs 429.15, up 1.23% on the day as on 12:49 IST on the NSE. The stock is down 20.6% in last one year as compared to a 7.07% spurt in NIFTY and a 17.6% spurt in the Nifty ...

Twenty years ago, these fascinating rides went into production or were unveiled in fully functional form, but today, they ...

The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood ...

The Chinese autonomous-driving company is aiming to make more inroads overseas this year, betting that robotaxis and related ...

Apollo Tyres Ltd is quoting at Rs 438.9, down 0.02% on the day as on 13:19 IST on the NSE. The stock tumbled 16.52% in last one year as compared to a 8.32% rally in NIFTY and a 21.18% spurt in the ...

In his remarks at Davos 2025, Kanwar highlighted the steady growth of economic ties between the US and India in the 21st ...

The MD acknowledged the sluggish demand environment in India, with commercial vehicle and passenger car sales under pressure.

The vintage tyre market has a new all-season tyre, combining the aesthetics demanded by classic car enthusiasts with performance characteristics suitable for all weather conditions. Apollo Tyres is ...

The therapy can cost anywhere between $350,000 and $700,000 globally. While Immuneel has brought it down to about ₹51 lakh to ...

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...

Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...